Sarasota biotech company noncompliant with NYSE listing standards

Oragenics was notified by the New York Stock Exchange American that its stockholders' equity total was below a required threshold.

Suicasmo via Wikimedia Commons
  • Manatee-Sarasota
  • Share

A Sarasota biotech company received notice from the New York Stock Exchange this week that it is out of compliance with the organization’s listing standards.

 

Continue reading your article
with a Business Observer subscription.
What's included:
  • ✓ Unlimited digital access to BusinessObserverFL.com
  • ✓ E-Newspaper app, digital replica of print edition
  • ✓ Mailed print newspaper every Friday (optional)
  • ✓ Newsletter of daily business news
Subscribe

Already subscribed? Sign in.

Latest News

  • February 3, 2026
St. Petersburg Gas Plant RFP draws nine proposals
  • February 3, 2026
DeSantis, MLB commissioner support Tampa Bay Rays' stadium plans
  • February 3, 2026
California hedge fund makes $1.1B offer to buy MarineMax
  • February 3, 2026
Landmark downtown Sarasota hotel torn down for new project

Sponsored Content